These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 10881373)
21. [The effect of alcohol on the regulation of iron metabolism]. Cylwik B; Chrostek L; Szmitkowski M Pol Merkur Lekarski; 2008 Sep; 25(147):273-5. PubMed ID: 19112848 [TBL] [Abstract][Full Text] [Related]
22. Basal endocrine status in African dietary iron overload. McNamara L; Panz VR; Raal FJ; Paiker J; Joffe BI; Gordeuk VR; MacPhail AP Endocrine; 2003 Aug; 21(3):241-4. PubMed ID: 14515008 [TBL] [Abstract][Full Text] [Related]
23. Insulin resistance-associated hepatic iron overload. Mendler MH; Turlin B; Moirand R; Jouanolle AM; Sapey T; Guyader D; Le Gall JY; Brissot P; David V; Deugnier Y Gastroenterology; 1999 Nov; 117(5):1155-63. PubMed ID: 10535879 [TBL] [Abstract][Full Text] [Related]
24. Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron. Asare GA; Paterson AC; Kew MC; Khan S; Mossanda KS J Pathol; 2006 Jan; 208(1):82-90. PubMed ID: 16278820 [TBL] [Abstract][Full Text] [Related]
25. Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance. Kohgo Y; Ikuta K; Ohtake T; Torimoto Y; Kato J World J Gastroenterol; 2007 Sep; 13(35):4699-706. PubMed ID: 17729391 [TBL] [Abstract][Full Text] [Related]
26. Iron overload in African Americans. Barton JC; Edwards CQ; Bertoli LF; Shroyer TW; Hudson SL Am J Med; 1995 Dec; 99(6):616-23. PubMed ID: 7503084 [TBL] [Abstract][Full Text] [Related]
32. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668 [TBL] [Abstract][Full Text] [Related]
33. [Iron overload disease: recent findings]. Licata A; Brucato V; Di Marco V; Barbaria F; Craxì A Ann Ital Med Int; 2004; 19(3):145-54. PubMed ID: 15529941 [TBL] [Abstract][Full Text] [Related]
34. Synergistic interaction between excess hepatic iron and alcohol ingestion in hepatic mutagenesis. Asare GA; Bronz M; Naidoo V; Kew MC Toxicology; 2008 Dec; 254(1-2):11-8. PubMed ID: 18852013 [TBL] [Abstract][Full Text] [Related]
35. Tuberculosis and iron overload in Africa: a review. Moyo VM; Gangaidzo IT; Gordeuk VR; Kiire CF; Macphail AP Cent Afr J Med; 1997 Nov; 43(11):334-9. PubMed ID: 9631102 [TBL] [Abstract][Full Text] [Related]
36. Hepatic iron in African Americans who underwent liver biopsy. Barton JC; Bertoli LF; Alford TJ; Barton JC; Edwards CQ Am J Med Sci; 2015 Jan; 349(1):50-5. PubMed ID: 25559280 [TBL] [Abstract][Full Text] [Related]
38. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update]. Ruivard M Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923 [TBL] [Abstract][Full Text] [Related]
39. Resveratrol mediates therapeutic hepatic effects in acquired and genetic murine models of iron-overload. Das SK; DesAulniers J; Dyck JR; Kassiri Z; Oudit GY Liver Int; 2016 Feb; 36(2):246-57. PubMed ID: 26077449 [TBL] [Abstract][Full Text] [Related]